Morgan Stanley Reiterates Underweight on PetMed Express, Maintains $17 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Erin Wright has reiterated an 'Underweight' rating on PetMed Express (NASDAQ:PETS) and maintained a price target of $17.
July 27, 2023 | 4:51 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has reiterated an 'Underweight' rating on PetMed Express, indicating a negative outlook for the stock. The price target remains at $17.
Analyst ratings often influence investor sentiment and can impact stock prices. An 'Underweight' rating suggests that the analyst believes the stock will underperform compared to other stocks, which could lead to a decrease in its price. The maintained price target of $17 also indicates that the analyst does not foresee significant growth in the stock's value in the near term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100